Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;78(7):645-655.
doi: 10.1007/s00393-019-0665-0.

[Antisynthetase syndromes]

[Article in German]
Affiliations
Review

[Antisynthetase syndromes]

[Article in German]
Jutta Bauhammer et al. Z Rheumatol. 2019 Sep.

Abstract

Antisynthetase syndromes (ASS) are rare autoimmune diseases. Characteristic is the presence of at least one of the three main symptoms myositis, interstitial lung disease (ILD) and arthritis with possible accompanying symptoms, such as mechanic's hands and feet, Raynaud's disease and/or fever in combination with detection of an aminoacyl-tRNA synthetase antibody in peripheral blood. In addition to myositis, ILD is a frequent and often predominant organ involvement and is responsible for morbidity and mortality. Autoantibodies to 11 aminoacyl-tRNA synthetases are known of which 8 have so far been associated with the clinical manifestation of ASS. The Jo-1 antibody is by far the most frequent one. The antibodies differ in the rate and severity of the main and accompanying symptoms. Treatment with selected immunosuppressive medication depends on the extent and severity of organ involvement. With a 5-year survival rate of approximately 90%, the Jo-1 syndrome has the best prognosis.

Keywords: Antisynthetase antibodies; Interstitial lung disease; Jo-1; Mechanic’s hands; Polymyositis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49 - PubMed
    1. Arthritis Rheum. 1980 Aug;23(8):881-8 - PubMed
    1. J Rheumatol. 2016 Aug;43(8):1566-74 - PubMed
    1. Clin Rheumatol. 2015 Sep;34(9):1563-9 - PubMed
    1. J Rheumatol. 2017 Feb;44(2):223-229 - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources